MEDICAL MARIJUANA: A CLINICAL HANDBOOK The Most Up-to-Date Insights on the Science of Cannabis and Its Medicinal Use

Medical Marijuana:  A Clinical Handbook book cover

Medical Marijuana: A Clinical Handbook

Medical Marijuana:  A Clinical Handbook back cover

Medical Marijuana: A Clinical Handbook

This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic.”

— Stephen Ross, MD, NYU Grossman School of Medicine

NEW YORK, NY, UNITED STATES, July 10, 2020 /EINPresswire.com/ — A new textbook, Medical Marijuana: A Clinical Handbook (Wolters Kluwer, September 2020), provides an objective look at the history and science of the plant and strips away the cultural and political baggage that often clouds any meaningful examination of cannabis's therapeutic value.

The authors, Drs. Samoon Ahmad and Kevin P. Hill, wrote the book to provide clinicians with the most accurate information available on cannabis and empower them to give their patients the best advice on treatment. Cannabis continues to be the single most misunderstood plant on Earth. It has been cultivated and used for thousands of years yet remains not just enigmatic but deeply polarizing.

"Both sides of the argument often fail to see through the fog of the culture war, and both sides are at times guilty of being more intent on winning a political argument than approaching the issue with a clear head and an agenda couched solely in the tradition of empiricism and science," Drs. Ahmad and Hill write in Medical Marijuana. "This book hopes to change that."

Both authors have extensive clinical experience and impressive resumes. Dr. Hill is an addiction specialist and currently Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center in Boston, an Associate Professor of Psychiatry at Harvard University, and author of Marijuana: The Unbiased Truth About the World's Most Popular Weed. Dr. Ahmad is a practicing physician in New York City, Founder of the Integrative Center for Wellness, and a Professor of Psychiatry at NYU Grossman School of Medicine. He has also written extensively about PTSD and coauthored multiple books, including recent editions of Kaplan & Sadock's Pocket Handbook of Clinical Psychiatry and Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment.

The authors focus on tetrahydrocannabinol (THC), which is the intoxicating substance in cannabis and typically the focal point of medical marijuana programs. They also examine the relevant science on many other cannabinoids found in the plant, especially cannabidiol (CBD). Included in the book is detailed analysis of local and federal laws governing the use of cannabis and a state-by-state guide for clinicians and patients. They have also created a companion website, cannabistextbook.com, that will monitor changes to local, state, and federal regulations as they occur, and share recently published cannabis-related research.

"This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic in my opinion," said Stephen Ross, M.D., Associate Professor of Psychiatry and Director of the Addictive Disorders and Experimental Therapeutics Research Laboratory at NYU Grossman School of Medicine. "Excellently written, the book provides an enormous amount of concise and clinically relevant information on everything related to medical cannabis including historical and regulatory aspects, the dizzying diversity of the many cannabis constituent components, review of the endocannabinoid system, relevant pharmacology, therapeutic preparations and the existing and potential clinical applications of medical cannabis throughout medicine, psychiatry and neurology."

The book enables clinicians to easily find information that is pertinent to specific body systems and disciplines. It also provides a wealth of information about the plant itself. The book begins by examining its classification, morphology, history and constituents. It then moves on to a cultural history of cannabis in the United States to provide a context for the regulations and laws currently governing its use. The book then describes the body's endocannabinoid system and the pharmacological profile of CBD and THC before moving on to specific applications for cannabis in specialty practices such as:

Endocrinology
Oncology
Gastroenterology
Neurology
Psychiatry
Gynecology
Rheumatology
Internal medicine
Ophthalmology
Hepatology
Dermatology

Finally, the authors describe the dangers of excessive cannabis use and potential adverse effects.

"It is our hope that we can eliminate unwarranted stigmas that continue to hound this quirky plant and to dispel any notions that cannabis is either a miracle drug or the devil's weed," the authors write. "If nothing else, we hope to provide our peers in the medical community with some degree of clarity so that they can make decisions based on the best available evidence and pass on accurate information to [their] patients."

About the Authors

Samoon Ahmad, M.D. is Professor in the Department of Psychiatry at NYU Grossman School of Medicine and serves as Unit Chief of Bellevue Medical Center's Inpatient Unit. A practicing physician for over twenty-five years, Dr. Ahmad has dedicated his professional life to helping individuals find balance in their mental and physical well-being. He founded the Integrative Center for Wellness to execute his innovative vision of incorporating psychiatric treatments with holistic therapies—including nutritional therapy, yoga, meditation, acupuncture, and plant-based medicines—to emphasize wellness of both the body and the mind. He specializes in treating patients with depression, anxiety, bipolar disorder, ADHD, stuttering, and weight management issues.

Kevin P. Hill, M.D., M.H.S. is an addiction psychiatrist and Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center and Associate Professor of Psychiatry at Harvard Medical School. Dr. Hill has conducted clinical research and written on a wide variety of topics including medical cannabis, cannabidiol (CBD), and addiction to alcohol, cannabis, and opioids. As a leading cannabis expert, he has spoken nationally and appeared often on radio and television on the topics of cannabis policy and treatment, offering a balanced, evidence-based stance on these issues.

Reviews

"Drs. Ahmad and Hill are to be congratulated on producing a book that is a complete and thorough guide to cannabis, is most timely and highly informative, and will appeal to a large audience."

-Benjamin Sadock, MD, Menas S. Gregory Professor of Psychiatry at the NYU Grossman School of Medicine and NYU Langone Health

"This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic."

-Stephen Ross, MD, Director of the Addictive Disorders and Experimental Therapeutics Research Laboratory and Associate Professor of Psychiatry at NYU Grossman School of Medicine

"The authors have written an extremely comprehensive book that will give readers
a more nuanced appreciation of cannabis. This includes its potential therapeutic value, its effects on the endocannabinoid system, and the parts it has played in cultures throughout the world."

-Joyce Cenali, Founding Partner & COO of Big Rock Partners, a strategic advisory firm

"Though written primarily for healthcare practitioners and clinicians,
anyone hoping to gain a greater understanding about cannabis and its therapeutic applications
will find this work extremely informative and helpful."

-Marion Mariathasan, CEO of Simplifya, the leading regulatory and compliance software platform serving the cannabis industry

Medical Marijuana: A Clinical Handbook
By Samoon Ahmad, M.D., and Kevin P. Hill, M.D., M.H.S.

Publisher: Wolters Kluwer
Publication Date: September 2020
Price: $69.99
ISBN: 9781975141899

Joe Flattery
kmacconnect
+1 917-474-2689
email us here


Source: EIN Presswire

HOUSE COMMITTEE VOTES TO HAND BLM $102 MILLION TO ROUND UP AMERICA’S ICONIC WILD HORSES

BLM Wild Horse Helicopter Roundup

BLM Wild Horse Helicopter Roundup

Animal Wellness Action Executive Director Marty Irby

Animal Wellness Action Executive Director Marty Irby

Suzanne Roy, American Wild Horse Campaign

Suzanne Roy, American Wild Horse Campaign

It’s time for Congress and the White House to rein in this costly, swampy spending spree that’s destroying our iconic American wild horse and burro populations.”

— Marty Irby, executive director at Animal Wellness Action

WASHINGTON, DC, USA, July 10, 2020 /EINPresswire.com/ — Today, two of the nation’s leading wild horse protection and humane organizations expressed disappointment with the U.S. House Appropriations Committee’s decision this morning to approve Fiscal Year 2021 Interior appropriations legislation giving the Bureau of Land Management (BLM) $102 million for its wild horse and burro program. In a report delivered to Congress in May, the agency said that it intended to use the funding to round up as many as 20,000 wild horses a year from Western public lands.

In passing the bill unamended, the committee ignored requests by key members, including U.S. House Natural Resources Chair Rep. Raul Grijalva, Public Lands Subcommittee Chair Deborah Haaland, and Rep. Marcy Kaptur (D-OH) of the Appropriations Committee, to require the BLM to implement humane fertility control as an alternative to cruel and unsustainable roundups and to prohibit surgical sterilization of wild horses and burros.

The bill carries over the 27% budget increase Congress awarded the BLM wild horse and burro program last year after the Humane Society of the United States, the ASPCA, and Return to Freedom joined the cattle industry in lobbying for a mass wild horse roundup plan. Although the groups portrayed the plan as a humane fertility control program that did not include brutal surgical sterilization methods, they have not supported efforts by Congressman Grijalva and others to require the BLM to fund humane, reversible fertility control programs or prohibit surgical sterilization.

“The House Appropriations Committee missed an opportunity to say ‘whoa’ to the BLM’s rampant mismanagement and mistreatment of our nation’s wild horses and burros,” said Suzanne Roy, Executive Director of the American Wild Horse Campaign. “Committee members just let down the American public and our iconic wild horses and burros by voting to hand over $100 million in taxpayer funds to the BLM to continue its unscientific, unsustainable and inhumane wild horse and burro roundup program.”

“It’s time for Congress and the White House to rein in this costly, swampy spending spree that’s destroying our iconic American wild horse and burro populations,” said Marty Irby, a lifelong horseman and executive director at Animal Wellness Action. “House and Senate Leadership and President Trump should saddle up and demand that our hard-earned tax dollars funding the BLM be used to implement PZP birth control instead of cruel helicopter chases, mass roundups, and the incarceration of the horses whose backs our nation was built upon.”

The groups said they support the Committee’s decision to continue the ban on slaughter of wild horses and burros under the jurisdiction of the BLM and U.S. Forest Service, but vowed to continue to fight for reform of the BLM’s woefully mismanaged wild horse roundup program, which the National Academy of Sciences has called “expensive and unproductive for the BLM and the public it serves.”

The bill now heads to the full House for a vote. The Senate version of the bill is still pending.

###

The American Wild Horse Campaign (AWHC) is the nation’s leading wild horse protection organization, with more than 700,000 supporters and followers nationwide. AWHC is dedicated to preserving the American wild horse in viable, free-roaming herds for generations to come, as part of our national heritage.

Animal Wellness Action (AWA) is a Washington, D.C.-based 501(c)(4) organization with a mission of helping animals by promoting legal standards forbidding cruelty. We champion causes that alleviate the suffering of companion animals, farm animals, and wildlife. We advocate for policies to stop dogfighting and cockfighting and other forms of malicious cruelty and to confront factory farming and other systemic forms of animal exploitation. To prevent cruelty, we promote enacting good public policies and we work to enforce those policies. To enact good laws, we must elect good lawmakers, and that’s why we remind voters which candidates care about our issues and which ones don’t. We believe helping animals helps us all.

Marty Irby
Animal Wellness Action
+1 202-821-5686
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Dr. David Samadi breaks down the stages of COVID-19 and best practices for treatment

Early detection, Intervention and treatment of Covid 19 is very critical. Different stages of this disease requires different treatments. Dr. Samadi

Early Detection of Covid 19 is the key, sooner treatment and intervention can happen the higher chance of recovery.The video describes different treatment options available to patients with covid 19”

— Dr. David Samadi

NEW YORK, NEW YORK, UNITED STATES, July 10, 2020 /EINPresswire.com/ — COVID-19 has proved to be a formidable enemy that has taken too many lives unnecessarily. From the beginning, when our understanding of this novel coronavirus was limited, it proved to be a tough contender to fight off. Fortunately, through numerous studies along with trial and error, our doctors and scientists have gained a tremendous amount of knowledge on how best to fight this deadly foe. When the stages of this viral infection are broken down, it becomes clearer on the best practices needed to win this fight.

Dr. David Samadi, Director of Men’s Health and Urologic Oncology at St. Francis Hospital on Long Island, New York, has written extensively on COVID-19 since the lockdown began in March. As a urologist and surgeon, he’s emphasized the same way he treats prostate cancer early on before it advances complicating treatment and survival rates, is the same way this virus should be treated.

“Like any disease, early detection and early intervention of treating it to prevent spread of the virus, is the way to go and is ultimately key in reducing mortality,” exclaimed Dr. Samadi. “If you have symptoms, be proactive. Get tested as soon as possible. If you test positive, prevent this virus from taking control by starting treatment early on.”

To help understand the stages of COVID-19 and what treatments are recommended, Dr. Samadi has broken the advancement of COVID-19 into 3 stages: Stage 1 is when the virus is beginning to ramp up creating a lot of inflammation.

“At stage one, this is when a person may have symptoms of a fever, chills, shortness of breath, chest pain, and body aches,” explained Dr. Samadi. “At this very beginning stage, it’s important to start a treatment of providing an antiobiotic of either amoxicillin or z-pak helping prevent bacterial pneumonia.”

Reducing inflammation during stage one is critical to prevent a cytokine storm which is the most dangerous and potentially life-threatening event related to COVID-19. For stage one, Dr. Samadi also recommends zinc, hydroxychloroquine, and a bronchodilator such as Budesonide helping open up the lungs to reduce inflammation helping a person breathe better while fighting off the virus. Preliminary data also shows that Ivermectin in this early stage could be very effective.

Stage two is called viral replication or duplication. At this stage, the virus begins to replicate and duplicate throughout the body affecting many different organs.

“In this stage, the best medication available is remdesivir,” said Dr. Samadi. “This medication reduces the replication of the virus by blocking the RNA polymerase, a key enzyme the virus needs to replicate its genetic material to proliferate or multiply in our body. If it’s blocked, it essentially stops the spread. For young adults who’ve died from the virus, often from blood clots or stroke, blood thinning medications are now advised and recommended for those in this age category”

People hovering between stage 2 and stage 3, may also benefit from using convalescent plasma. “Plasma is the largest part of your blood making up about 55 percent of its overall content,” explained Dr. Samadi. “People who have recovered from COVID-19 develop antibodies which are found in plasma. Studies have found that plasma removed from these patients with antibodies, referred to as convalescent plasma, can be beneficial for some patients with severe COVID-19 boosting their ability to fight off the virus.”

If a person advances on to stage 3, multiple organ failure affecting the kidneys, heart, and lungs, has occurred. At this point, the prognosis is poor of only 20-30% of patients who reach this stage will recover. Back in March and April, placing these patients on ventilators was widespread. Since then and because of the poor prognosis once patients were ventilated, physicians have questioned their use stating that these patients could instead be treated with less intensive respiratory support.

“Studies show that instead of automatically relying on ventilators which take over the breathing for the patient, to instead consider placing patients who’ve advanced to stage three on dexamethasone which can reduce the risk of death by 30%,” said Dr. Samadi. “Mechanical ventilation is an invasive traumatic treatment and comes with risks such as severe lung damage. We now know that ventilators are not the right treatment for coronavirus.”

“I personally have added a stage 4 to recovery from COVID-19,” exclaimed Dr. Samadi. “The power of prayer. As a surgeon, I’ve operated on thousands and thousands of patients with prostate cancer with robotic surgery. My own personal belief and faith in God has been my guide as I take care of these men. As a result, I’ve had very, very low complications or issues with my patients. While I would like to take the credit, I know it belongs to this omnipotent power that takes over when we reach out in prayer. It’s helped me this far and I plan on continuing to use it.”

Dr. David Samadi is the Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Long Island. He’s a renowned and highly successful board certified Urologic Oncologist Expert and Robotic Surgeon in New York City, regarded as one of the leading prostate surgeons in the U.S., with a vast expertise in prostate cancer treatment and Robotic-Assisted Laparoscopic Prostatectomy. Visit Dr. Samadi’s websites at robotic oncology and prostate cancer 911.

david b samadi
roboticoncology
+1 2123655000
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Different stages of Corona Virus and treatment option Dr. Samadi’s Conslusion


Source: EIN Presswire

The House Committee on Appropriations to Discuss FY 2021 Interior and Environment Markups Today

Photo of a curious young horse at the feeding hub

Curious little one at a hub

Photo of The WPM system is supported by solar power and satellite communications for 24/7 operability

Solar power and satellites provide 24/7 operability

Funding for the FY 2021 wild horse and burro program will be addressed in the Interior markup session.

ALBUQUERQUE, NEW MEXICO, UNITED STATES, July 10, 2020 /EINPresswire.com/ — $102,620,000 for the 2021 wild horse and burro program is included in today’s House Committee markup session.

Thanks to the vision of the founder of Wildlife Protection Management, Roch Hart, roundups and holding pens are no longer the only way to address wild horse populations. It was the goal of WPM to develop the first hands free and the most humane system available and that has been accomplished with their patented technology. In addition, their work has the potential to lower Bureau of Land Management spending by reducing the need for helicopter roundups and short and long term holding costs.

With the recent release of the Congressionally requested U.S. Department of Interior Bureau of Land Management Report to Congress regarding the future of America’s wild horses and the BLM’s request for additional long term funding to implement the plan, it is an important time to consider this new technology. Roch Hart states “The WPM Remote Wildlife Vaccine Delivery System is ready to start now. And it won’t cost billions. Our system relies on technology rather than the stress of roundups to deliver contraceptives and microchips to the animals. In addition to wild horses, our WPM Remote Wildlife Vaccine Delivery System can be adapted to many other species.”

If you have questions or are interested in making arrangements for an on-site field interview please contact Roch Hart.

Roch Hart
Wildlife Protection Management
+1 505-252-0301
email us here


Source: EIN Presswire

CANNSUN MEDHEL GROUP PLC STRENGTHENS ITS BOARD AND CREATES A WOMENS HEALTH DIVISION

DUBLIN , IRELAND , July 10, 2020 /EINPresswire.com/ — Cannsun Medhel Group PLC ("Cannsun" or the "Company"), a 103 year old Biopharmaceutical company focused on developing and commercializing new medicines to optimize human potential with operations in South Africa, Greece, Thailand and Lesotho, today announced the nomination of Donaghue Woodman to their Board of Directors and head of their Women’s Health Division including overseeing the R&D of its Adaptogens which includes CBD, Psilocybin and other botanicals. Cannsun is also please to announce the nomination of Rorisang Ntai to the Board of Directors.

Donaghue Woodman, Head of Women’s Health. Born and raised in Cape Town, South Africa Dona attended the University of Cape Town and holds an MBA from Management College of Southern Africa. Ms. Woodman has extensive background in biochemistry and pharmacology working with the South African Herbal Medicine and Science Institute, focusing on active molecules and natural medicines. Dona has nine years experience in sales and marketing within the pharmaceutical industry holding positions at Abbot Laboratories and Adcock Ingram. Dona has worked in both the private and public sector including areas of Women’s Health, CNS, CVS, Dermatology, Cancer and pain management. Dona has a passion for people and business and is currently a keynote motivational speaker for the Global Business Roundtable.

Rorisang Ntai, Finance South Africa. Born in Durban, South Africa and now based in Johannesburg, Rorisang holds a B Com degree from the University of South Africa and is currently studying towards a Post Graduate Diploma in Management Practice at the University of Cape Town Graduate School of Business. Rori has 18 years experience in finance and entrepreneurship initially as an investment officer with FNB Asset Management & Trust Services and later as an investment analyst with Citadel Investment Services. He has built an extensive network of private equity, asset management & large financial institutions to assist in financing activities with our South African manufacturing and distribution assets.

“Co-Founder Pholoso Malatji of Limpopo, South Africa and myself wanted to grow Cannsun internationally and maintain our roots in Africa. The appointment of Donaghue brings a wealth of experience in the health sector and market access fields and joins the Board at a pivotal time as we prepare to ramp up operations on three continents. Her insights and skillset will be valuable resources as we develop and implement evidence-based medicine and women specific consumer based health products. Donaghue will become our first female African based Director along with fellow South African Rorisang Ntai who with his strong contacts in the region will help increase our footprint. This is important to us as we see Africa as an underrepresented market with massive potential and having successful business entrepreneurs join our board with expedite our growth.” commented President and Chief Executive Officer of Cannsun Medhel David Parry.

Global efforts to improve the health of women largely focus on improving sexual and reproductive health. However, the global burden of disease has changed significantly over the past decades. Currently, the greatest burden of death and disability among women is attributable to non-communicable diseases (NCDs). Historically, most medical research was conducted in men and the findings from such studies were assumed to be equally applicable to women. Sex differences and gender disparities in health and disease have therefore long been unknown and/or ignored. Since the number of women in studies is increasing, evidence for clinically meaningful differences between men and women across all areas of health and disease has emerged.
Cannsun Women’s Health Portal aims to educate woman irrespective of age on feminine issues that they could experience throughout their lifetime. It aids in building strong relationship with the consumer and our organization. The woman’s health portfolio caters to all woman irrespective of class and race. Our vision and main focus areas are creating natural therapies that target some of the biggest health issues woman in developing countries are facing such as Bacterial Vaginosis linked to increase in HIV and STI’s, PMS which impacts all woman from a socioeconomic standpoint and treatment resistant depression heightened by PMS and menopause.

For more information on women’s health and our BV product line see the link below.

https://cannsunmedhel.com/investors/

About Medhel
First established in 1918 and now with new management and ownership, Cannsun is re-emerging as a science-led, global, healthcare company focused on leveraging its existing infrastructure and reputation in the manufacture and distribution of established healthcare products and pharmaceuticals, as well as building a vertically integrated cannabinoid division. The Company currently distributes products to thousands of healthcare professionals and pharmacies in 21 countries. Our current projected growth will enable us to deepen and extend our reach, so that we can help people everywhere live better, healthier lives.

www.cannsunmedhel.com

Contact:
Rorisang Ntai
Director
Phone: +27 82 575 1144
Email: rorisang@cannsun.com

Nikolaos Manias
Senior Business Development
Phone: +30 695 181 0901
Email: n.manias@cannsun.com

Greg Bealer
Director of Finance
Phone: +1 780 970 3789
Email: g.bealer@cannsun.com

David Parry
Cannsun Medhel Group PLC
+ 1 604-889-2188
email us here


Source: EIN Presswire

Global Immunity Boosting Food Products Market Grows At Huge Rate Of 39.6% In 2020

Immunity Boosting Food Products Market Report

Immunity Boosting Food Products Market Global Report 2020-30: Covid 19 Implications And Growth

Major players in the immunity boosting food products market are Danone, Nestle, Blue Diamond Growers, Diamond Foods, Dole Food Company, Pinnacle Foods.

LONDON, GREATER LONDON, UK, July 10, 2020 /EINPresswire.com/ — The global immunity boosting food products market is expected to grow from $16.31 billion in 2019 to $22.76 billion in 2020 at a rate of 39.6%. The exponential growth is mainly due to the outbreak of COVID-19 that raised awareness about boosting immunity in the human body to protect from being infected by the virus. The market is then expected to reach $24.02 billion in 2023 at a rate of 1.81%. The increasing consciousness about health and fitness to live a healthier lifestyle will drive the immunity-boosting food products market. However, the high cost of raw materials and lack of awareness among people about the benefits of the products are hampering the growth of the immunity-boosting food products market.

The immunity boosting food products market consists of sales of food products used to boost the immune system. The market consists of revenues generated by sales of immunity-boosting food products by companies producing them.

Request For A Free Sample For The Global Immunity Boosting Food Products Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3236&type=smp

The global immunity boosting food products market is further segmented based on type and geography.

By Product Type: Herbs & Spices, Nuts & Seeds, Fruits & Vegetables, Dairy-Based Products, Probiotics And Prebiotics, Others

By Form: Tablets, Capsules, Powder, Liquid, Others

By Distribution Channel: Store-Based, Non-Store-Based

By Geography: The global immunity boosting food products market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American immunity boosting food products market accounts for the largest share in the global immunity boosting food products market.

Read More On The Report For The Global Immunity Boosting Food Products Market At:
https://www.thebusinessresearchcompany.com/report/immunity-boosting-food-products-market-global-report-2020-30-covid-19-implications-and-growth

Trends In The Immunity Boosting Food Products Market

Instant immunity booster products are increasingly being used to boost immune function, which is used when under stress in the modern world. For instance, in January 2020, ZAND, the natural lozenge brand in health food stores known for herbal-based immune support, has launched the first rapid immunity product, Immune Fast. This breakthrough new supplement delivers clinically supported immune support whenever and wherever at work, the airport, school, large gatherings, anywhere. Thus, it is used on the spot to boost the immune system within two hours.

Immunity Boosting Food Products Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides immunity boosting food products market overviews, analyzes and forecasts immunity boosting food products market size and growth for the global immunity boosting food products market, immunity boosting food products market share, immunity boosting food products market players, immunity boosting food products market size, immunity boosting food products market segments and geographies, immunity boosting food products market trends, immunity boosting food products market drivers and immunity boosting food products market restraints, immunity boosting food products market’s leading competitors’ revenues, profiles and market shares. The immunity boosting food products market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Immunity Boosting Food Products Global Market Report 2020 from The Business Research Company for information on the following:
Markets Covered: Global Immunity Boosting Food Products Market
Data Segmentations: Immunity Boosting Food Products Market Size, Global And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Immunity Boosting Food Products Market Organizations Covered: Danone SA, Nestle S.A., Blue Diamond Growers, Diamond Foods, LLC., Dole Food Company, Inc., Pinnacle Foods Corp., Olam International, Hines Nut Company, Fonterra Group Cooperative Limited, Associated British Foods PLC.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa
Time Series: Five years historic (2015-19) and forecast (2019-23)
Other Information And Analyses: PESTEL analysis, immunity boosting food products market customer information, immunity boosting food products market product/service analysis – product examples, immunity boosting food products market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global immunity boosting food products market in 2020 – countries offering most new opportunities
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Immunity Boosting Food Products Industry: The report explains a number of strategies for companies in the immunity boosting food products market, based on industry trends and company analysis.
Opportunities For Companies In The Immunity Boosting Food Products Sector: The report reveals where the global immunity boosting food products industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Immunity Boosting Food Products Global Market Report 2020:
Drugs for Immunotherapy Global Market Report 2020
Functional Food Market Global Report 2020-30: COVID-19 Growth and Change
Autoimmune Disease Diagnosis Market Global Report 2020-30: COVID-19 Growth and Change

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Specialty Enzymes Market Forecast To 2023

Specialty Enzymes Market Report

Specialty Enzymes Market Global Report 2020-30: Covid 19 Implications And Growth

Major players in the specialty enzymes market are BASF, Novozymes, Roche Holding, Codexis, Specialty Enzymes & Probiotics, Sanofi, and Amano Enzyme.

LONDON, GREATER LONDON, UK, July 10, 2020 /EINPresswire.com/ — The global specialty enzymes market is expected to grow from $3.79 billion in 2019 to $4.49 billion in 2020 at a rate of 18.46%. The growth is mainly due to the COVID-19 that has urged individuals to focus on health and strengthening the immune system, thus increasing the demand for foods, supplements, and drinks containing probiotics. The market is expected to reach $5.35 billion in 2023 at a rate of 6.05%. The growing number of biotech research companies following increasing investments in biotech R&D is expected to boost the specialty enzymes market. However, ethical and societal issues are factors that will slow down the market growth during the forecast period.
The specialty enzymes market consists of sales of specialty enzymes which are proteins acting as biocatalysts to accelerate the rate of reactions. The revenue generated by the market involves the sales of specialty enzymes that include carbohydrases, proteases, lipases, among others in liquid or dry form, which are produced either from microorganisms, plants or animals. Specialty enzymes are primarily used in pharmaceutical, diagnostics, animal nutrition, food & beverage, research, and biotechnology.
Request For A Free Sample For The Global Specialty Enzymes Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3242&type=smp
The global specialty enzymes market is further segmented based on type and geography.
By Type: Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, Oxidase & Hydratases, Others
By Source: Microorganisms, Animals, Plants
By Application: Pharmaceutical, Diagnostics, Research & Biotechnology, Food & Beverage, Animal Nutrition, Others
By Geography: The global specialty enzymes market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American specialty enzymes market accounts for the largest share in the global specialty enzymes market.
Read More On The Report For The Global Specialty Enzymes Market At:
https://www.thebusinessresearchcompany.com/report/specialty-enzymes-market-global-report-2020-30-covid-19-implications-and-growth
Trends In The Specialty Enzymes Market
Technological advancements show opportunities for the production of enzyme products in a more efficient way. Challenges such as complexity in maintaining pH, operational high temperature of specialty enzymes and significant cost of maintenance of specialty enzyme products paves way for technological advancements.
Specialty Enzymes Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides specialty enzymes market overviews, analyzes and forecasts specialty enzymes market size and growth for the global specialty enzymes market, specialty enzymes market share, specialty enzymes market players, specialty enzymes market size, specialty enzymes market segments and geographies, specialty enzymes market trends, specialty enzymes market drivers and specialty enzymes market restraints, specialty enzymes market’s leading competitors’ revenues, profiles and market shares. The specialty enzymes market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Specialty Enzymes Global Market Report 2020 from The Business Research Company for information on the following:
Markets Covered: Global Specialty Enzymes Market

Data Segmentations: Specialty Enzymes Market Size, Global And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Specialty Enzymes Market Organizations Covered: BASF SE, Novozymes A/S, Roche Holding AG, Codexis Inc., Specialty Enzymes & Probiotics, Advanced Enzyme Technologies Ltd., BBI Solutions, E. I. du Pont de Nemours and Company, Sanofi, Amano Enzyme, Inc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa
Time Series: Five years historic (2015-19) and forecast (2019-23)
Other Information And Analyses: PESTEL analysis, specialty enzymes market customer information, specialty enzymes market product/service analysis – product examples, specialty enzymes market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global specialty enzymes market in 2020 – countries offering most new opportunities
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Specialty Enzymes Industry: The report explains a number of strategies for companies in the specialty enzymes market, based on industry trends and company analysis.
Opportunities For Companies In The Specialty Enzymes Sector: The report reveals where the global specialty enzymes industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Specialty Enzymes Global Market Report 2020:
Microbiome Therapeutics Global Market Report 2020
Specialty Foods Market Global Report 2020-30: COVID-19 Growth and Change
Digestive Enzymes Market Global Report 2020

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Automotive Tester Market Report 2020 by Technology, Future Trends, Opportunities, Top Key Players and more…

A new market study, titled “Global Automotive Tester Market Research Report 2020”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, July 10, 2020 /EINPresswire.com/ — Automotive Tester Market

Global Automotive Tester Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

The major players in the market include Horiba, Bosch, Siemens, AVL List, ABB, Meidensha, ACTIA, MTS, etc.

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4851959-global-automotive-tester-market-research-report-2020

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Market Segment Analysis
The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Chassis Dynamometer
Engine Dynamometer
Vehicle Emission Test System
Wheel Alignment Tester

Segment by Application
OEM
Aftermarket

Global Automotive Tester Market: Regional Analysis
The report offers in-depth assessment of the growth and other aspects of the Automotive Tester market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Automotive Tester Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

View Detailed Report at https://www.wiseguyreports.com/reports/4851959-global-automotive-tester-market-research-report-2020

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Global Inhalers Market Analysis 2020 – Dynamics, Trends, Revenue, Regional Segmented, Outlook & Forecast Till 2026

Wiseguyreports.Com Adds “Inhalers Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2026” To Its Research Database

PUNE , MAHARASHTRA, INDIA, July 10, 2020 /EINPresswire.com/ — Global Inhalers Industry

New Study Reports “Inhalers Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Market Overview

The report on the Global Inhalers Market 2020-2026 illustrates an in-depth analysis of segments and sub-sectors in the regional and international Global Inhalers Market. The research highlights vital factors such as the effect of constraints, drivers, and macro indicators on the regional and Global Inhalers Market both for the current scenario and for the near future. A comprehensive and reliable presentation of the data provides useful business insight on the forecasts, patterns, and values of the Global Inhalers Market.

Try Free Sample of Global Inhalers Market @   https://www.wiseguyreports.com/sample-request/5561737-global-inhalers-market-insights-and-forecast-to-2026

The major vendors covered:
GlaxoSmithKline
Merck
AstraZeneca
Boehringer-Ingelheim
3M
Teva
Sunovion Pharmaceuticals
Aristopharma
Novartis
Vectura Group
MannKind
Respirices
Orion Pharm
Hovione

Segment by Type, the Inhalers market is segmented into
Metered Dose Inhalers
Dry Powder Inhalers
Nasal Inhalers
Other

Segment by Application, the Inhalers market is segmented into
Hospital
Clinic
Respiratory Care Centers
Others

Report covers:

Comprehensive research methodology of Global Inhalers Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Inhalers Market.
Insights about market determinants which are stimulating the Global Inhalers Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

Competitive Landscape and Inhalers Market Share Analysis

Inhalers market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Inhalers by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Inhalers business, the date to enter into the Inhalers market, Inhalers product introduction, recent developments, etc.

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5561737-global-inhalers-market-insights-and-forecast-to-2026

Some points from table of content:

1 Study Coverage
2 Executive Summary
3 Market Size by Manufacturers
4 Inhalers Production by Regions
5 Inhalers Consumption by Region
6 Market Size by Type (2015-2026)
7 Market Size by Application (2015-2026)
8 Corporate Profiles
8.1 GlaxoSmithKline
8.1.1 GlaxoSmithKline Corporation Information
8.1.2 GlaxoSmithKline Overview
8.1.3 GlaxoSmithKline Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 GlaxoSmithKline Product Description
8.1.5 GlaxoSmithKline Related Developments
8.2 Merck
8.3 AstraZeneca
8.4 Boehringer-Ingelheim
8.5 3M
8.6 Teva
8.7 Sunovion Pharmaceuticals
8.8 Aristopharma
8.9 Novartis
8.10 Vectura Group
8.11 MannKind
8.12 Respirices
8.13 Orion Pharm
8.14 Hovione
9 Inhalers Production Forecast by Regions
10 Inhalers Consumption Forecast by Region
11 Value Chain and Sales Channels Analysis
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
13 Key Finding in The Global Inhalers Study
14 Appendix

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

Healthcare Informatics Market 2020 Global Analysis,Research,Review,Applications And Forecast To 2025

PUNE, MAHARASTRA, INDIA, July 10, 2020 /EINPresswire.com/ —
WiseGuyReports.com Publish A New Market Research Report on –“ Healthcare Informatics Market 2020 Global Analysis,Research,Review,Applications And Forecast To 2025”.

Healthcare Informatics Market 2020

Summary: –

Health informatics is a specialization that links IT, communications and healthcare to improve patient care.
Health informatics is a term that describes the acquisition, storage, retrieval and use of healthcare information to foster better collaboration among a patient’s various healthcare providers. Health informatics plays a critical role in the push toward healthcare reform.
Health informatics is an evolving specialization that links information technology, communications and healthcare to improve the quality and safety of patient care.

Get a Free Sample Report of Healthcare Informatics Market Analysis @ https://www.wiseguyreports.com/sample-request/4465142-global-healthcare-informatics-market-size-status-and-forecast-2019-2025

For more information or any query mail at sales@wiseguyreports.com

Major Key Players of Healthcare Informatics Industry are :-

Optum
Cerner Corp
Cognizant
Change Healthcare
Philips
Epic
Dell EMC
Conduent
Leidos
Allscripts
Conifer Health Solutions
Softheon
athenahealth
Wipro Limited
GE Healthcare
Nuance Communications
3M Health Information Systems
Omnicell
Ciox Health
Wolters Kluwer Health
Cotiviti Holding Inc.
Poper Technologies, Inc.
Oracle
IBM
InterSystems
NetApp Inc.
HMS
NextGen Healthcare
eClinicalWorks
MEDITECH

The study covers estimated global Healthcare Informatics market value and growth rate, as checked by analysts. This Global Healthcare Informatics Market Analysis summarizes existing market dynamics, barriers, engines, and metrics, and offers a perspective for significant segments. Growth in the sector is also anticipated in various industries. The essence of the research also includes detailed segmental analysis. Which offers a better understanding of market dynamics. The global Healthcare Informatics industry also offers comprehensive country-level assessments with a geographical overview of North America , Latin America, Asia-Pacific Europe and the Middle East & Africa. The report also provides a thorough description of the business strategies used by the major players as well as new entrants.

Methodology of research

The analysis has its foundations based on the expert data analysts using systematic methods. The analytical approach involves collecting feedback from researchers simply to have them evaluated and closely reviewed for the duration of the study to have accurate market forecasts. The study approach also involves interviews with industry-leading influencers that render crucial and practical primary research. The secondary approach offers a deeper insight into the supply-demand relation. The business strategy implemented in the study involves extensive sector-wide data review and understanding. Principal and secondary data were collected using methods. Data researchers used publicly available resources, such as annual reports, SEC statements and white papers, to achieve an inclusive industry understanding. The research approach clearly illustrates the purpose of getting it assessed against different parameters in order to achieve a systematic market assessment. The valuable insights improve visibility and benefit against peers.

Competitive Dynamics

The study also describes the leading players in the global Healthcare Informatics industry, and analyzes their market position. The research also integrates new business entrants and an changing approach to their market place. Moreover, the report offers insights into annual sales, the geographic scope of global Healthcare Informatics market participants, both domestically and regionally, along with their growth strategies, and R&D initiatives. The report is composed of industry leaders' suggestions to increase investment in R&D projects and marketing strategies to retain their market share throughout the study period. In addition , the study covers mergers , acquisitions, strategic business alliances and short-term joint ventures to maintain the competitive presence of the global Healthcare Informatics industry.

Enquiry About Healthcare Informatics Market Report @ https://www.wiseguyreports.com/enquiry/4465142-global-healthcare-informatics-market-size-status-and-forecast-2019-2025

Table of Contents – Major Key Points

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 North America

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

Continued…

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire